US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Sernova Biotherapeutics Inc (PSH0) 銘柄情報

Sernova Biotherapeutics Inc (PSH0)

0.0906

0.00

( 0.00% )

更新日時： 17:06:36

Sernova Biotherapeutics Inc (PSH0) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.0906

( - )

買値

0.091

売値

0.0946

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.0906

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

117,360 €

発行済株式数

377,000,009

配当利回り

PER

-4.08

1 株当たり利益 (EPS)

-0.04

歳入

-

純利益

-11.91M

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longe... Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.sernova.com

本社

Mississauga, Canada

設立

-

Sernova Biotherapeutics Inc is listed in the sector of the Tradegate (DE) with ticker PSH0. The last closing price for Sernova Biotherapeutics was 0.09 €. Over the last year, Sernova Biotherapeutics shares have traded in a share price range of 0.00 € to 0.00 €.

Sernova Biotherapeutics currently has 377,000,009 shares in issue. The market capitalisation of Sernova Biotherapeutics is 34.16 € million. Sernova Biotherapeutics has a price to earnings ratio (PE ratio) of -4.08.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PSH0 - Frequently Asked Questions (FAQ)

What is the current Sernova Biotherapeutics Inc share price?

The current share price of Sernova Biotherapeutics Inc is 0.0906 €

How many Sernova Biotherapeutics Inc shares are in issue?

Sernova Biotherapeutics Inc has 377,000,009 shares in issue

What is the market cap of Sernova Biotherapeutics Inc?

The market capitalisation of Sernova Biotherapeutics Inc is EUR 34.16M

What is the 1 year trading range for Sernova Biotherapeutics Inc share price?

Sernova Biotherapeutics Inc has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Sernova Biotherapeutics Inc?

The price to earnings ratio of Sernova Biotherapeutics Inc is -4.08

What is the registered address of Sernova Biotherapeutics Inc?

The registered address for Sernova Biotherapeutics Inc is RPO Central Parkway, Mississauga, Ontario, L5A 4H2

What is the Sernova Biotherapeutics Inc website address?

The website address for Sernova Biotherapeutics Inc is www.sernova.com

CA Market News

CA Market News 3分前

F3 Targets New Discoveries in 2026 Summer Exploration Program Across PLNJune 16, 2026 5:00 AM
NewsfileNew Drill Ta

US Market News

US Market News 3分前

Orkin Invites Students to Imagine Life in 2151 Through National Virtual Insect Science FairJune 16, 2026 5:24 AM
PR Newswire (US) "Insect 2151" Challenges Teens to Reimagine the Future Through Insect-Inspired Innovation, Offering $180,000 in Scholarship

US Market News

US Market News 18分前

NIQ and Unlimitail Collaborate to Deliver the Next Generation of Omnichannel Retail Media Insights & Measurement Across Retailers and CountriesJune 16, 2026 5:00 AM
Business Wire Enabling advertisers to prove ROI across retailers, markets, and channels with int

US Market News

US Market News 18分前

Ooma Names Travelers Care Winner of Inaugural Small Business Spotlight AwardJune 16, 2026 5:00 AM
Business Wire Travel assistance company recognized for its mission-driven service and innovative use of communications technology to support vulnerable travelers a

CA Market News

CA Market News 18分前

Tamarack Valley Energy Ltd. Closes Previously Announced Sale of Charlie Lake AssetsJune 16, 2026 5:00 AM
PR Newswire (Canada) TSX: TVE class="legendSpanClass"CALGARY, AB, class="legendSpanClass"June 16, 2026 /CNW/ - Tamarack Valley

US Market News

US Market News 18分前

Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and InfrastructureJune 16, 2026 5:00 AM
PR Newswire (US) The company's revolutionary, pate

theorysuit

theorysuit 18分前

Lmfao buyout. Debt ridden, dilution scam will be bought out? Hopium at its finest. That's why it is dilution scam. Oh wait is this the cure all cancer vaccine....platform company....lmfao.

StonkMaster

StonkMaster 21分前

This can only mean one thing ...

BUYOUT!

theorysuit

theorysuit 23分前

This is exactly what this company is ......vehicle to pay LP. Even if UK is approved by miracle......there is no path to revenue 100% a dilution scam. That's what the paid apologists are here for......to keep hope alive so that the dilution can continue. Best example of the keep hope aliv

Ribo

$CGAC needs a contract like SharonAI got with NVIDIA

https://www.nasdaq.com/press-release/sharon-ai-announces-six-year-strategic-compute-collaboration-nvidia-2026-06-12

Mohammad111

Mohammad111 30分前

That's the big question.
Will it decouple from BTC? The good thing is, as you said, when it moves up, the ratio is 3 to 1.

US Market News

US Market News 33分前

Appian and Deloitte Deliver New AI-Powered Policing SolutionsJune 16, 2026 4:45 AM
PR Newswire (US) Expanded collaboration includes new joint policing solutions in the UK and broader investments in enterprise modernisation worldwide

P-Rawl

P-Rawl 41分前

ASCAP, the second biggest PRO in the US, reported an annual revenue of $1.945 billion in 2025. They have approximately 1.9 thousand employees.
https://musicrow.com/2026/02/ascap-posts-record-breaking-1-945-billion-in-revenue/

Jake claims Pro Music Rights is the third biggest PR

jimr1717

jimr1717 51分前

And you seem surprised. I told you that this filth is a fraud

chicks0123

chicks0123 56分前

Good morning CLNVers

Ranb2khz

Ranb2khz 1時間前

You Are So Good To Me – Mac Powell (lyrics)

https://www.youtube.com/watch?v=sLXY7dssZPQ

https://www.youtube.com/watch?v=sLXY7dssZPQ

•

Methinks

Methinks 1時間前

https://www.hampshirechronicle.co.uk/news/26185479.university-winchester-wins-cyber-security-funding/
I'll teach them a thing or two - W.A.V.E.

Methinks

Methinks 1時間前

https://www.universiteitleiden.nl/en/news/2026/06/how-do-you-prepare-for-the-threats-of-tomorrow
Easy - ACT NOW WITH WAVE.

SDCRBS

SDCRBS 1時間前

Sagacious = “Showing unusually good judgment before everyone else sees it.”
It’s not just “smart.”
It’s smart at the right time, before the crowd, based on insight rather than hype.

When investors call a move sagacious, they mean:

You recognized the under

Methinks

Methinks 1時間前

https://cybersecuritynews.com/optinmonster-plugin-exposes-wordpress-sites/
ACT NOW WITH WAVE.

Investor2014

Investor2014 1時間前

One must be a believer around here, as reflected by the emojis. To some an idea is more important than fact.

RuudSaltis

RuudSaltis 2時間前

The shell announcement wasn’t falling out of heaven. Everything has a reason. As told earlier this announcement wil trigger new serious investors!

10thMountain

10thMountain 2時間前

EMBR…YEP! This is the calm before the storm. Here’s a company post.TWO definitive agreements signed and more updates coming….

https://x.com/embarrdownsinc/status/2065463502832382124?s=46

Sernova Biotherapeutics

Vontobel Financial Produ...

Morgan Stanley Issuer Ca...

BlackRock Global Funds W...

Bmo Ultra Shortterm Bond...

Criteria Caixa SA Sole P...

Investec Bnk 26

6.378% Usd A Nts 02/24/2...

3D Printing ETF

Bank of Montreal Issuer ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。